Effect of Homocysteine-lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease

NCT00693589 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease
Endothelial Dysfunction

Interventions

DRUG: folic acid, vitamin B12 and B6 and rosuvastatin

Sponsor

Insel Gruppe AG, University Hospital Bern